Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Role of complement and complement membrane attack complex in laser-induced choroidal neovascularization.

Puran S Bora1, Jeong-Hyeon Sohn, Jose M C Cruz

  • 1Department of Ophthalmology and Visual Sciences, Kentucky Lions Eye Center, University of Louisville, 301E Muhammad Ali Boulevard, Louisville, KY 40202, USA. psbora01@louisville.edu

Journal of Immunology (Baltimore, Md. : 1950)
|December 22, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

RHO1-2 meganuclease gene editing targets human P23H rhodopsin-induced retinitis pigmentosa to rejuvenate rods and maintain cones.

bioRxiv : the preprint server for biology·2025
Same author

Mice deficient of G-protein coupled receptor 3 (GPR3) developed severe experimental autoimmune uveitis (EAU) through increased effector T cell activities.

Journal of immunology (Baltimore, Md. : 1950)·2025
Same author

Involvement of tdTomato-Tagged RPE cells in a mouse PVR model with enzymatically compromised retina.

Scientific reports·2025
Same author

Metabolic transcriptomics dictate responses of cone photoreceptors to retinitis pigmentosa.

Cell reports·2024
Same author

Genetic Insights into Age-Related Macular Degeneration.

Biomedicines·2024
Same author

Colorimetric Analyses of the Optic Nerve Head and Retina Indicate Increased Blood Flow After Vitrectomy.

Translational vision science & technology·2024

Complement activation, specifically membrane attack complex (MAC) formation, is crucial for choroidal neovascularization (CNV) development in a mouse model. Inhibiting complement pathways effectively reduced CNV and associated angiogenic factors.

Area of Science:

  • Ophthalmology
  • Immunology
  • Angiogenesis research

Background:

  • Choroidal neovascularization (CNV) is a primary cause of vision loss in age-related macular degeneration.
  • The underlying mechanisms of CNV, particularly the role of inflammation and complement, remain incompletely understood.
  • Experimental models are crucial for investigating CNV pathogenesis.

Purpose of the Study:

  • To investigate the role of the complement system in the development of laser-induced choroidal neovascularization (CNV) in a murine model.
  • To determine if complement activation, specifically membrane attack complex (MAC) formation, is essential for CNV.
  • To assess the impact of complement depletion on angiogenic growth factors in CNV.

Main Methods:

  • Laser photocoagulation was used to induce CNV in a murine model (C57BL/6 mice).

Related Experiment Videos

  • Complement deposition (C3 and MAC) was analyzed in neovascular complexes.
  • Complement was depleted using cobra venom factor, and C3(-/-) mice were utilized.
  • Anti-murine C6 antibodies were used to inhibit MAC formation.
  • Levels of angiogenic factors (VEGF, TGF-beta2, bFGF) were measured.

    • Main Results:

    • C3 and MAC deposition were observed in laser-induced CNV lesions.
    • Complement depletion significantly inhibited CNV development.
    • CNV did not develop in C3(-/-) mice.
    • Inhibition of MAC formation also suppressed CNV.
    • Complement depletion markedly reduced levels of VEGF, TGF-beta2, and bFGF.

    Conclusions:

    • Complement activation, particularly MAC formation, is essential for the development of experimental CNV.
    • The complement system plays a critical role in regulating angiogenic factors during CNV.
    • These findings suggest a potential therapeutic target for CNV and related angiogenesis diseases.